Home
Conditions
Pemphigus

Clinical trial condition

Pemphigus

Explore clinical trials studying Pemphigus. Study availability and eligibility vary by location and protocol.

42 public trials 7 recruiting studies

Refine in advanced search Browse all conditions

Pemphigus trial results

Completed

Use of Infliximab for the Treatment of Pemphigus Vulgaris

NCT00283712

Conditions: Autoimmune Diseases, Immune System Diseases, Pemphigus, +3 more
Locations: Norris Cancer Center, University of Southern California Los Angeles, California, United States

University of Iowa Hospitals and Clinics Iowa City, Iowa, United States

Duke University Medical Center Durham, North Carolina, United States

University of Pennsylvania Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Immunoadsorption, Dexamethasone Pulse Therapy and Rituximab for Pemphigus

NCT00656656

Conditions: Autoimmune Diseases, Immune System Diseases, Pemphigus, +3 more
Locations: Department of Dermatology, University of Luebeck Lübeck, Schleswig-Holstein, Germany

View Trial Details

Completed

Study of Etanercept (Enbrel) in the Treatment of Pemphigus Vulgaris

NCT00135720

Conditions: Autoimmune Diseases, Immune System Diseases, Pemphigus, +4 more
Locations: Clinical Unit for Research Trials in Skin Boston, Massachusetts, United States

View Trial Details

Completed

Effect of Anti CD20 in Pemphigus Desease

NCT00213512

Conditions: Autoimmune Diseases, Immune System Diseases, Pemphigus, +3 more
Locations: UH-Rouen Rouen, Seine maritime, France

View Trial Details

Completed

The RITAI Cohort: An Observational Study on Rituximab Off-label Use for Auto-immune Disorders

NCT00960713

Conditions: Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Autoimmune, +21 more
Locations: Service de médecine interne, hôpital Purpan, place du Dr Baylac Toulouse, France

View Trial Details

Completed

Long-term Clinical and Biological Evaluation of Patients With Severe Forms of Pemphigus Treated by Rituximab

NCT01299857

Conditions: Autoimmune Diseases, Immune System Diseases, Pemphigus, +3 more
Locations: UH-Rouen Rouen, Seine maritime,, France

View Trial Details

Completed

A Study to Assess the Effect of CellCept (Mycophenolate Mofetil) and Reduced Corticosteroids in Patients With Active Pemphigus Vulgaris (PV)

NCT00683930

Conditions: Autoimmune Diseases, Immune System Diseases, Pemphigus, +4 more
Locations: Los Angeles, California, United States

Atlanta, Georgia, United States

Baltimore, Maryland, United States

St Louis, Missouri, United States

View all 26 locations

View Trial Details

Completed

Azathioprine Versus Placebo in Pemphigus Vulgaris Treated With Prednisolone

NCT00626678

Conditions: Autoimmune Diseases, Immune System Diseases, Pemphigus, +4 more
Locations: Department of Dermatology, Tehran University of Medical Sciences Tehran, Tehran Province, Iran

View Trial Details

Completed

Phase II Study of High-Dose Cyclophosphamide in Patients With Refractory Pemphigus

NCT00010413

Conditions: Autoimmune Diseases, Communicable Diseases, Disease Attributes, +9 more
Locations: Johns Hopkins University School of Medicine Baltimore, Maryland, United States

View Trial Details

Completed

Use of KC706 for the Treatment of Pemphigus Vulgaris

NCT00606749

Conditions: Autoimmune Diseases, Immune System Diseases, Pemphigus, +4 more
Locations: Victoria Werth, MD Philadelphia, Pennsylvania, United States

View Trial Details

Pemphigus

Pemphigus trial results

Related conditions